# Senzime acquires Respiratory Motion for up to $44M

Senzime AB has signed an agreement to acquire 100% of Respiratory Motion, Inc. for an initial consideration of USD 19 million plus potential earn-out of up to USD 25 million. The acquisition expands Senzime's patient monitoring portfolio.

- Type: Acquisition
- Announced: 2022-06-01
- Where: United States
- Value: $19.0M
- Status: announced
- Products: patient monitoring systems, respiratory function monitors
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Senzime](https://endata.com/companies/61840.md) (acquirer)
- [Respiratory Motion, Inc.](https://endata.com/companies/63228.md) (target)

## Sources

- [senzime.com](https://www.senzime.com/en/press-releases/senzime-has-entered-agreement-acquire-us-company-respiratory-motion-2026238), 2022-06-01: "Through the acquisition, Senzime expands its product portfolio within the market for monitoring of vital signs and extends the Company’s capability to capture a larger share of the patient journey outside of the operating room."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.